Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 12, 1998, Pages 1201-1205

  Chan, F K L ^a   Sung, J J Y ^a   Suen, R ^a   Lee, Y T ^a   Wu, J C Y ^a   Leung, W K ^a   Chan, H L Y ^a   Lai, A C W ^a   Lau, J Y W ^a   Ng, E K W ^a   Chung, S C S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH CITRATE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; TETRACYCLINE; UREA;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; ULCER HEALING;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PEPTIC ULCER HEMORRHAGE; TETRACYCLINE;

EID: 7844241911     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00434.x     Document Type: Article

References (20)

1. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
2. European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection: the Maastricht Consensus 1997; 41: 8-13.
3. Yeomans ND, Tulassay Z, Juhasz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998; 338: 719-26.
4. Hawkey CJ, Karrasch JA, Szcepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998; 338: 727-34.
5. Hawkey CJ, Tullassay Z, Szcepanski L, et al. Failure of Helicobacter pylori eradication to influence site-specific relapse in high risk NSAID users: results of a large six month double blind randomised controlled clinical trial. Gastroenterology 1998; 114: A145(Abstract).
6. Taha AS, Sturrock RD, Russell RI. Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori. Gut 1995; 36: 334-6.
7. Ekstrom P, Carling L, Wetterhus S, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic Multicentre Study. Scand J Gastroenterol 1996; 31: 753-8.
8. Kim JG, Graham DY. The Misoprostol Study Group. Helicobacter pylori infection and the development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. Am J Gastroenterol 1994; 89: 203-7.
9. Chan FKL, Sung JY, Chung SCS, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997; 350: 975-9.
10. Bianchi Porro G, Parente F, Imbesi V, Montrone F, Caruso I. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users: response to omeprazole dual therapy. Gut 1996; 59: 22-6.
11. Hudson N, Balsitis M, Filipowicz F, Hawkey CJ. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 1993; 34: 748-51.
12. Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110: 725-32.
13. Campbell D, Shah N, Winton B, Karvois D, Rose P, Huang B. Effect of H. pylori status on healing of gastric ulcer in patients continuing to take NSAIDs and treated with lansoprazole or ranitidine. Gastroenterology 1998; 114: A83(Abstract).
14. Caruso I, Bianchi Porro G. Gastroscopic evaluation of anti-inflammatory agents. Br Med J 1990; 280: 75-8.
15. Laine L. NSAID-induced mucosal injury. What's the Score? Gastroenterology 1991; 101: 555-7.
16. McCarthy DM. NSAID-induced gastrointestinal damage: a critical review of prophylaxis and therapy. J Clin Gastroenterol 1990; 12: 813-20.
17. Heresbach D, Raoul JL, Bretagne JF, et al. Helicobacter pylori: a risk factor and severity of non-steroidal anti-inflammatory drug induced gastropathy. Gut 1992; 33: 1608-11.
18. Chan FKL, Yung MY, Ling TKW, Leung WK, Chung SCS, Sung JY. What is the true impact of metronidazole resistance on the efficacy of bismuth-triple therapy? Gut 1998; 43 (Suppl. 2): A84 (Abstract).
19. Chan FKL, Sung JY, Suen R, et al. Eradication of H. pylori versus maintenance acid suppression to prevent recurrent ulcer hemorrhage in high risk NSAID users: a prospective randomized study. Gastroenterology 1998; 114: A87(Abstract).
20. Hawkey GM, Stack WA, Pearson G, Everitt S, Logan RFA, Hawkey CJ. Non-steroidal anti-inflammatory drugs, aspirin and Helicobacter pylori as risk factors for bleeding peptic ulcers. Gut 1997; 41(Suppl. 3): A5(Abstract).